Oppenheimer Asset Management Inc. Has $1.44 Million Stake in Axcelis Technologies, Inc. $ACLS

Oppenheimer Asset Management Inc. boosted its position in shares of Axcelis Technologies, Inc. (NASDAQ:ACLSFree Report) by 111.5% during the 3rd quarter, HoldingsChannel reports. The firm owned 14,747 shares of the semiconductor company’s stock after buying an additional 7,775 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Axcelis Technologies were worth $1,440,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in ACLS. Allspring Global Investments Holdings LLC raised its position in Axcelis Technologies by 1,344.8% during the third quarter. Allspring Global Investments Holdings LLC now owns 109,628 shares of the semiconductor company’s stock valued at $10,388,000 after buying an additional 102,040 shares during the period. Summit Global Investments purchased a new position in Axcelis Technologies during the 3rd quarter valued at about $789,000. Squarepoint Ops LLC increased its holdings in shares of Axcelis Technologies by 37.0% in the 2nd quarter. Squarepoint Ops LLC now owns 100,023 shares of the semiconductor company’s stock valued at $6,971,000 after purchasing an additional 27,021 shares during the period. AlphaQuest LLC purchased a new stake in shares of Axcelis Technologies in the third quarter worth approximately $1,347,000. Finally, Boston Partners boosted its holdings in shares of Axcelis Technologies by 42.3% during the second quarter. Boston Partners now owns 474,043 shares of the semiconductor company’s stock worth $33,616,000 after purchasing an additional 141,004 shares during the period. 89.98% of the stock is owned by institutional investors and hedge funds.

Axcelis Technologies Stock Up 4.4%

ACLS stock opened at $94.55 on Friday. The firm has a market cap of $2.90 billion, a PE ratio of 22.35 and a beta of 1.77. Axcelis Technologies, Inc. has a 1 year low of $40.40 and a 1 year high of $102.93. The company has a fifty day simple moving average of $88.23 and a 200 day simple moving average of $85.09. The company has a current ratio of 4.95, a quick ratio of 3.32 and a debt-to-equity ratio of 0.04.

Analyst Upgrades and Downgrades

ACLS has been the topic of several research reports. Wall Street Zen lowered shares of Axcelis Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, January 3rd. Bank of America upped their price target on shares of Axcelis Technologies from $90.00 to $100.00 and gave the stock an “underperform” rating in a research note on Tuesday, January 13th. B. Riley Financial increased their price objective on Axcelis Technologies from $84.00 to $94.00 and gave the stock a “neutral” rating in a report on Wednesday, January 21st. Zacks Research cut Axcelis Technologies from a “strong-buy” rating to a “hold” rating in a research report on Friday, December 5th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Axcelis Technologies in a research note on Monday, December 22nd. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $102.25.

View Our Latest Report on ACLS

Insider Transactions at Axcelis Technologies

In other news, Director Jorge Titinger sold 2,000 shares of the company’s stock in a transaction dated Wednesday, December 17th. The stock was sold at an average price of $86.05, for a total transaction of $172,100.00. Following the completion of the sale, the director owned 7,477 shares in the company, valued at approximately $643,395.85. This represents a 21.10% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Gerald M. Blumenstock sold 3,034 shares of the stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $89.46, for a total value of $271,421.64. Following the transaction, the executive vice president directly owned 18,661 shares in the company, valued at approximately $1,669,413.06. This represents a 13.98% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.48% of the stock is owned by insiders.

Axcelis Technologies Profile

(Free Report)

Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.

The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.

Recommended Stories

Want to see what other hedge funds are holding ACLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axcelis Technologies, Inc. (NASDAQ:ACLSFree Report).

Institutional Ownership by Quarter for Axcelis Technologies (NASDAQ:ACLS)

Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.